Globeflex Capital L P Coherus Bio Sciences, Inc. Transaction History

Globeflex Capital L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$14.42 - $21.39 $407,119 - $603,903	-28,233 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$16.56 - $18.94 $10,879 - $12,443	-657 Reduced 2.27%	28,233 $491,000
Q3 2020 Nov 13, 2020	BUY	$17.41 - $19.89 $26,480 - $30,252	1,521 Added 5.56%	28,890 $530,000
Q2 2020 Aug 12, 2020	BUY	$14.43 - $19.16 $309,292 - $410,675	21,434 Added 361.15%	27,369 $489,000
Q4 2019 Feb 07, 2020	BUY	$16.33 - $21.37 $96,918 - $126,830	5,935 New	5,935 $107,000

143

82.7M

79.1K

100K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $80.8M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

Stay updated on Globeflex Capital L P with notifications on news.